Le Lézard
Classified in: Business, Covid-19 virus
Subjects: EARNINGS, Dividend

Oconee Federal Financial Corp. Announces Annual Financial Results


Oconee Federal Financial Corp. (Nasdaq: OFED) (the "Company"), the holding company for Oconee Federal Savings and Loan Association ("Oconee Federal"), announced today net income of $4.1 million, or $0.72 per diluted share, for the year ended June 30, 2022, which was the same as the net income of $4.1 million, or $0.72 per diluted share, for the year ended June 30, 2021.

June 30, 2022 Year End Summary:

"The year ended June 30, 2022 was a good year for Oconee Federal. Net income remained stable at $4.1 million when compared to the year ended June 30, 2021," stated Curtis T. Evatt, President and Chief Executive Officer. "We had modest growth in both our loan and deposit balances. Loans increased 1.8% and deposits increased 4.5% over the prior year balances. In light of today's ever changing economic, competitive and interest rate environments, as well as the continued economic disruptions as a result of the global COVID-19 pandemic, we view our current financial statement position as stable and our Company prepared to succeed as we look forward to our opportunities in the future. "

Cash Dividend Declared

Total dividends paid during the year ended June 30, 2022 were $2.2 million. On July 28, 2022, the Board of Directors of the Company declared a quarterly cash dividend of $0.10 per share of the Company's common stock payable to stockholders of record as of August 11, 2022, which is payable on August 25, 2022.

About Oconee Federal

Oconee Federal Financial Corp. (NASDAQ Capital Market: OFED) is the holding company of Oconee Federal Savings and Loan Association. Oconee Federal Savings and Loan Association is a federally chartered savings and loan association founded in 1924 and headquartered in Seneca, South Carolina. Oconee Federal Savings and Loan Association is a community oriented financial institution operating eight full-service branch locations in Oconee County, South Carolina, Pickens County, South Carolina, Stephens County, Georgia and Rabun County, Georgia.

Forward-Looking Statements

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on current expectations, estimates and projections about the Company's and the Association's industry, and management's beliefs and assumptions. Words such as anticipates, expects, intends, plans, believes, estimates and variations of such words and expressions are intended to identify fiscal year forward-looking statements. Such statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to forecast. Therefore, actual results may differ materially from those expressed or forecast in such forward-looking statements. The Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information or otherwise.


These press releases may also interest you

at 21:08
BioVaxys Technology Corp. ("BioVaxys" or the "Company") announces that it has closed the first tranche ("Tranche 1") of a non-brokered private placement (the "Private Placement").  Pursuant to Tranche 1 of the Private Placement, the Company has...

at 21:03
The 19th International Finance Forum Annual Meeting will take place between December 2 to 4 in Guangzhou with packed meetings and events centred on the theme of "the Ever-Changing World: Reshaping Our Shared Future". The Meeting is co-organised by...

at 20:30
Data Bridge Market research has recently released expansive research titled "MEMS And Sensors Market" guarantees you will remain better informed than your competition. A team involved in preparing this MEMS And Sensors market research report has kept...

at 20:05
Organigram Holdings Inc. , (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the fourth quarter and year ended August 31, 2022 ("Q4 Fiscal 2022" or "Fiscal 2022"). "In Fiscal 2022, our innovative...

at 19:10
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that the Investigational New Drug (IND) application of ASC11, an oral inhibitor drug candidate targeting 3-chymotrypsin like protease (3CLpro) for COVID-19, has been accepted by China...

at 19:04
The Hempshire Group, Inc. (formerly Hoist Capital Corp.) ("Hempshire" or the "Company" ) is pleased to announce the release of its financial results for the three and nine months ended September 30, 2022. Selected financial information is outlined...



News published on 12 august 2022 at 11:05 and distributed by: